Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 8.2B 2.18B 1.99B 1.83B 1.67B 3.13B 202B 3.29B 22.32B 8.87B 110B 8.02B 347B P/E 2026 *
16.7x
P/E 2027 * 15.1x
Enterprise Value 7.87B 2.1B 1.91B 1.76B 1.6B 3B 194B 3.16B 21.43B 8.52B 106B 7.71B 333B EV / Sales 2026 *
4.77x
EV / Sales 2027 * 4.28x
Free-Float
38.61%
Yield 2026 *
3.4%
Yield 2027 * 3.75%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day+0.09%
1 week+0.09%
Current month-2.34%
1 month-4.80%
3 months-16.83%
6 months-24.74%
Current year-17.71%
1 week 115.3
Extreme 115.3
120.9
1 month 112.2
Extreme 112.2
124.3
Current year 112.2
Extreme 112.2
163.7
1 year 112.2
Extreme 112.2
163.7
3 years 104.6
Extreme 104.6
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 15/05/2021
Director of Finance/CFO 62 13/01/2013
Chief Operating Officer 31 01/09/2021
Director TitleAgeSince
Chairman 66 19/06/2022
Director/Board Member 41 19/06/2022
Director/Board Member 65 19/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%+0.09%-21.83%+6.84% 2.18B
-0.30%-6.68%+29.12%+125.42% 1,204B
+1.25%-5.35%+33.19%+80.42% 643B
+0.94%-2.99%+24.73%+106.93% 501B
-0.60%-1.95%+27.26%+67.32% 378B
+0.69%-9.50%+40.80%+30.23% 327B
+0.41%-4.70%+27.23%+51.59% 285B
+0.81%-4.08%-1.74%+32.71% 270B
-0.15%-6.45%+29.63%+64.18% 237B
-0.06%-0.98%+33.15%+118.99% 207B
Average +0.34%-4.31%+22.15%+68.46% 405B
Weighted average by Cap. +0.39%-5.21%+28.01%+87.55%

Financials

2026 *2027 *
Net sales 1.65B 439M 400M 369M 335M 629M 40.69B 661M 4.49B 1.78B 22.22B 1.61B 69.75B 1.83B 488M 444M 409M 372M 698M 45.15B 734M 4.98B 1.98B 24.66B 1.79B 77.39B
Net income 491M 131M 119M 110M 99.83M 187M 12.11B 197M 1.34B 531M 6.61B 480M 20.76B 540M 144M 131M 121M 110M 206M 13.34B 217M 1.47B 585M 7.28B 529M 22.86B
Net Debt -326M -86.89M -79.14M -72.92M -66.33M -124M -8.05B -131M -887M -353M -4.39B -319M -13.79B -364M -97.01M -88.36M -81.42M -74.06M -139M -8.98B -146M -991M -394M -4.91B -356M -15.4B
Projected Income Statement - Annual - Jamjoom Pharmaceuticals Factory Company
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company is a Saudi Arabia-based entity which is primarily engaged in manufacturing, production, marketing, and distribution of pharmaceutical products. The Company is organized into two segments which are pharmaceutical products, consumer health products. Pharmaceutical products represent medicines or drugs, and they are essential for the prevention and treatment of diseases, and protection of public health; Consumer health products represent products used to support personal well-being, maintain health, or address specific health-related needs. The activities of the Company include producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. The Company operates approximately 7 branches in Saudi Arabia.
Employees
-
Date Price Change Volume
19/11/26 SAR 117.10 +0.09% 16,881
18/11/26 SAR 117.00 -1.85% 60,278
17/11/26 SAR 119.20 +1.79% 51,458
16/11/26 SAR 117.10 +0.17% 38,877
15/11/26 SAR 116.90 -0.09% 18,071
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Jamjoom Pharmaceuticals Factory Company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
117.10SAR
Average target price
152.16SAR
Spread / Average Target
+29.94%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Jamjoom Pharmaceuticals Factory Company
  1. Stock Market
  2. Stocks
  3. 4015 Stock